San Jose, CA (India Currents)

The announcement that Robert F. Kennedy Jr. would take the top job at the HSS under incoming president Donald Trump sent ripples through the biopharmaceutical industry. The markets responded almost immediately to his strong anti-vaccine stance. Shares of vaccine makers fell. More shockwaves erupted after Kennedy's lawyer asked the government to revoke its approval of 13 vaccines, including the polio vaccine.